Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in late 2020, Undeterred Capital is based in Los Angeles and focuses on early-stage investments. The firm manages a portfolio of 20 companies, primarily in North America, with a check size ranging from $500,000 to $1 million. Their investment strategy emphasizes partnerships with founders innovating in biological platforms and applied robotics.
Undeterred Capital invests between $500,000 and $1 million, primarily targeting pre-seed and seed-stage companies. The firm concentrates on two main sectors: Biological Platforms and Applied Robotics, with over 80% of its investments occurring at the pre-seed stage or earlier. This focus allows them to support groundbreaking scientific and technological advancements.
Notable portfolio companies include Parallel Bio, which accelerates curative immunotherapies via AI-powered organoid screening; Shinkei, reinventing fish processing for sustainability; and Portal, engaged in next-generation cell engineering. Other companies include Curative, Index Biosystems, Zoo, Newlight, AstroForge, Polymath Robotics, Circe, Nanopath, Vibe Bio, TRIC Robotics, Tessel, CheMastery, Mobius, Lavo, Ellis Bio, Imaware, Bindle, AOA Dx, and Cascade.
Submit your pitch through their form at undeterredcapital.com or email info@undeterredcapital.com with your deck.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.